MVIC AB’s Post

Want to learn more about hot topics for pharmaceuticals regarding market access & public procurement? Join us at our upcoming PharmaAccess event in Paris! Register here: https://lnkd.in/ebcy8pSF hashtag #marketaccess hashtag #pharmaceuticals hashtag #publicprocurement

This encapsulates the progress towards innovation that China has made in the biopharma sector. It is now clearly feasible to aim for simultaneous approval China/US for new indications, including for biologics. Just a few years ago, this would have been an unrealistic goal. Just one step of the market access challenge. But a critical one. #china

Why do we need Public Pharma in Europe? Why does it matter? Tim Joye, Vice-President of Medics for the People/Geneeskunde voor het Volk- GVHV/Médecine pour le Peuple - MPLP (Belgium)—a member organization of the Public Pharma for Europe Coalition—shares his insights on these pressing questions. #PPfE #PublicPharma #publicpharmaeurope #publicpharmaforeurope

With deep #industryexpertise , huge #atmp #technicalexcellence and our #digitalfirst approach, the pinnacle is having our own #cellandgenetherapies #qp . Have a listen to what Neil has to say about adthera bio and digitally enabled #qbd mindsets

Very interesting panel discussion this morning at the Outsourcing in Clinical Trials Event Series DACH 2024 with Cornelia Baumgartner- Diolaiuti , Ina Meyer , Andrea Sauerland and Enrico Perfler moderated by Dr. Nicolas Schneider about the challenges in clinical trials in the DACH region. I’d be interested about your comments. What are your specific challenges and hurdles? #pharma #cdmo #clinicalsupplies #clinicaltrials #healthcare

Meet the team - Listen to our Head of strategy, Matt Symes, discuss how we support our clients develop a commercialization strategy taking into account key considerations such as supply-chain, scale-out manufacturing and quality. #cdmo #regenerativemedicine #digitalfirst #celltherapy #immunotherapy #innovation #gmp #clinicaltrials #atmp #advancedtherapies #personalizedmedicine #bestinclass #rightfirsttime #celltherapymanufacturing #innovation #digital #personinplant #continousimprovement #collaboration #excellence #pointofcare #distributedmanufacturing #strategy #supplychain

Please join me and many other Medical Affairs experts at the 16th annual #MedAffairs #Transformation conference on November 14 in Zurich, Switzerland. I'll share my perspectives on 'the impact of medical affairs on the corporate's mid and long-term strategy' and join a panel session to discuss 'the Impact of internal and external stakeholder value needs on Medical Affairs capabilities development' Please learn more about the program and find out how to register below. Looking forward to engaging discussions and catching up with friends! #ViaViatris #EvidenceLifeScience

Sue O'Leary Executive Vice President, Evidence & Access, Prime will be moderating a panel discussion tomorrow on ‘Optimising Value Demonstration and Evidence in Rare Disease’!    🗓️ Date: Thursday, 24th October 🕒 Time: 11:55 AM 📍 Location: Theatre 6, WODC Please join her alongside industry expert panelists Stuart Mealing, Jennifer Quinn, Mukesh Sharma, PhD and Simon S. for a deep dive into this critical topic. This session will explore how access bodies like NICE assess rare disease evidence during health technology assessments. The discussion will also delve into innovative methods beyond clinical trials that pharma companies can leverage to demonstrate product value. Additionally, we will discuss how pharmaceutical companies can internally organize their processes to ensure efficient and effective evidence planning while adapting to changing roles and responsibilities. We’re looking forward to an insightful discussion! #WODC #RareDiseases #ValueDemonstration #RealWorldEvidence #PanelDiscussion